A mobile app used with an insulin pump that led to 224 injuries was recalled by Tandem Diabetes Care, the FDA announced today. The recall is for the 2.7 version of the Apple iOS t:connect mobile app, ...

NEW YORK (Reuters Health) - Many children and teens using insulin pumps to control type 1 diabetes experience skin problems at the infusion catheter insertion site, but few report thinking about ...

Pump vs control sites had greater vessel density, fibrosis, fibrinogen, and inflammation including eosinophils, insulin-like-growth factor-1 (IGF-1), and transforming growth factor (TGF) β-3, as well ...

(Reuters Health) – - When diabetic patients report problems with their insulin pumps, the pump manufacturers collect that information – but there’s no easy way for researchers to analyze the data ...

Medtronic has issued a second alert letter to patients regarding shortened battery life of the MiniMed 600 and 700 series insulin pumps. The affected products include the MiniMed 630G, 670G, 770G, and ...

Medtronic MiniMed insulin pumps are being recalled due to an issue that can lead to incorrect dosing. The affected pumps include the MiniMed 630G and MiniMed 670G. The recall affects 322,055 devices.

According to the US FDA, at least 224 diabetes patients suffered from injuries linked to a glitch on t:connect iOS which shut down insulin pumps prematurely. isens usa from Unsplash Insulin pumps are ...

Federal regulators have warned Johnson & Johnson that it could face fines and other sanctions for selling faulty insulin pumps and delaying disclosures of serious injuries to diabetics who used them.

Administering a daily injection of insulin or wearing some form of insulin pump might be irritating, but they are far better than having to deal with some of the serious ...

A shorter-than-expected battery life prompted a voluntary recall of certain insulin pumps from Medtronic's MiniMed 600 and 700 series, the FDA detailed on Thursday. Affecting all lots, serial numbers, ...

All is not well in the land of insulin pumps -- the devices that deliver insulin to mostly Type 1 diabetics -- and the FDA wants to put a spotlight on the problem. Noting that there had been 18 ...

The widening quality problems at health giant Johnson & Johnson have former regulators and analysts mystified, as yet another J&J business — at least the seventh — has come under scrutiny. The lapses ...